← Back to Screener
Japer Therapeutics, Inc. Warrants (JSPRW)
Price$0.02
Favorite Metrics
Price vs S&P 500 (26W)-85.19%
Price vs S&P 500 (4W)1.50%
All Metrics
Price vs S&P 500 (YTD)-47.74%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.02M
52-Week High$0.18
26-Week Price Return-81.41%
13-Week Price Return-83.28%
3-Month Return Std Dev299.34%
Year-to-Date Return-47.88%
5-Day Price Return12.37%
Month-to-Date Return-4.57%
Price vs S&P 500 (13W)-83.34%
Beta3.25x
52-Week Low$0.02
Industry Peers — Biological Products(89)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
JSPRWJaper Therapeutics, Inc. Warrants | — | — | — | — | $0.02 |
AMGNAmgen Inc | 5.13x | 9.95% | 73.30% | 2.93% | $349.39 |
GILDGilead Sciences Inc | 5.84x | 2.40% | 78.83% | 133.64% | $138.55 |
ARGXargenx SE American Depositary Shares | 12.46x | 89.56% | 150.91% | — | $828.35 |
BNTXBioNTech SE American Depositary Share | 8.75x | -11.81% | 84.21% | — | $102.12 |
BIIBBiogen Inc. Common Stock | 2.60x | 2.22% | 75.69% | -18.77% | $176.02 |
MRNAModerna, Inc. Common Stock | 11.02x | -39.93% | 70.32% | — | $54.68 |
NBIXNeurocrine Biosciences Inc | 4.49x | 21.45% | 98.18% | 2.31% | $128.41 |
EXELExelixis Inc | 4.96x | 6.85% | 96.39% | 31.10% | $44.38 |
TECHBio-Techne Corp. | 7.60x | 1.64% | 66.60% | -20.58% | $57.36 |
HALOHalozyme Therapeutics, Inc. | 5.74x | 37.55% | 83.62% | 22.89% | $66.64 |
About
Jasper Therapeutics is a clinical-stage biotech company developing safer conditioning agents and advanced stem cell engineering technologies to expand the use of hematopoietic stem cell transplantation and ex vivo gene therapy. The company's platform aims to enable broader patient access to stem cell-based treatments by improving efficacy and safety outcomes.